fda approval in cinv, new asco guideline for dcis, promising findings in aml, and more
Published 7 years ago • 167 plays • Length 5:18
Download video MP4
Download video MP3
Similar videos
-
4:37
cancer advance of the year, fda approval for cinv, breakthrough designation in tnbc, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
6:48
fda approval in prostate cancer, phase iii data in breast cancer, and more
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
9:41
asco's cancer advance of the year, fda approval in nets, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
12:40
fda approval in aml, priority review in prostate cancer, ema chmp recommendations, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
8:51
fda approvals in prostate cancer and nsclc, priority review in aml, odac in all, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
12:17
fda approvals in breast cancer and prostate cancer, priority review in breast cancer, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
12:19
fda approvals in hcc, rcc, and cll, and odac recommendations
-
7:59
fda approval in head and neck cancer, european approval in nsclc, and more
Clip.africa.com - Privacy-policy